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 We are interested in understanding the development of reciprocal inhibition, an 
important sensory-motor circuit that prevents co-contraction of antagonist muscles during 
locomotion.  This effect is mediated by a subset of glycinergic neurons termed Ia 
inhibitory interneurons (IaINs).  Transgenic mouse models are useful in helping to 
identify subsets of neurons in developing animals. In this thesis we first wanted to test the 
BAC-GlyT2-eGFP mice model by measuring GFP expression overlap in neurons with 
glycine in late-stage embryos (E17.5) and early postnatal animals (P0/P1).  Our results 
suggest more than 98% of glycinergic neurons at these stages also express GFP in GlyT2-
EGFP transgenic animals.  Secondly, we quantitatively measured the number of IaINs at 
P0 and P1 using a combination of GFP expression in this transgenic model together with 
other immunohistochemical markers of IaINs.  We found that IaINs account for 17% of 
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 The main goals of this thesis are 1) to validate the BAC-GlyT2-eGFP mice model 
by carefully measuring the eGFP-Glycine expression in neurons from lamina VII at late 
embryonic and early postnatal stages in a quantitative manner and; 2) to identify Ia 
inhibitory interneurons (IaINs) and measure them in a quantitative manner at postnatal 
stages using the BAC-GlyT2-eGFP transgenic mice model. This study will build a strong 
foundation for the future work in our lab.   
 Our lab is involved in looking into mechanisms that guide the development of 
sensory-motor neuronal circuits, in particular the mechanisms involved in the maturation 
of the reciprocal inhibition circuit. Reciprocal inhibition (RI) acts to prevent co-
contraction of antagonist flexor and extensor muscles to facilitate normal locomotion.  A 
unique class of glycinergic interneuron, the Ia inhibitory neuron (IaIN), mediates this 
inhibition by integrating sensory feedback from the periphery and controlling the motor 
neuron (MN) firing during locomotion (Eccles and Lundberg, 1958). IaINs receive 
synaptic contacts from Ia afferents bringing signals from muscles in the limb and make 
synapses on the efferent MNs that project to limb muscles with antagonistic function at 
the same joints. Excitatory synaptic connections between extensor sensory afferents and 
extensor efferent MNs cause the extensor muscles to contract; at the same time, the IaIN 
interneurons activated by extensor Ia afferents diminishes electrical activity in flexor 
efferent MNs and cause 
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flexor muscles to relax (Figure. 1). Increasing knowledge regarding the development of 
normal RI circuit function will shed some light on understanding the changes in RI seen 
in disease and injury state. 
 Locomotion is still under development at birth in humans, unlike some other 
mammals that quickly acquire motor skills of posture and the ability to walk at the time 
of birth. Therefore, one may speculate that the development of sensory motor circuits 
occurs postnatally based on experience dependent mechanisms. The assembly of sensory 
motor circuits during development is dependent on the close interaction between the 
experience-driven processes and programs of genetic predetermination.  This makes 
motor circuits highly flexible, enabling reading, modifying and activating the motor 
output in response to the changing environment throughout life (Ladle et al., 2007). On 
the other hand, basic circuits of the sensory motor system seem to be pre-formed in 
embryos in many species. Reciprocal inhibition is present in newborn human infants (Mc 
Donough et al., 2001). Although humans undergo significant postnatal maturation in 
terms of locomotor skills, the presence of basic sensory-motor circuits at birth implies 
earlier specification of the basic elements that create these circuits.  
 RI is mediated by a single class of glycinergic neurons termed IaINs. The RI 
pathway includes many complex neuronal connections, but very little is known about the 
role and anatomical organization of IaINs in the early developmental stages of this 
circuit.  It is known, however, that IaINs are glycinergic, and fortunately, we have a 
transgenic mouse model available in our lab that specifically labels glycinergic neurons.  
This model, generated by Zeilhofer and his team is a bacterial artificial chromosome 






Figure 1: Reciprocal Inhibition Circuit. The circuit mediating reciprocal inhibition is 
composed of Ia afferents (illustrated using red dashed lines) originating from muscle 
spindle primary endings and exerting monosynaptic excitatory actions on both synergist 
MNs (pink) and IaINs (yellow) which act to inhibit the MNs of antagonist muscle. The 
subset of IaINs contacted by flexor-Ia afferents is different than those contacted by 
extensor-Ia afferents. Hence, flexor Ia-afferents only evoke inhibition of extensor MNs, 
and extensor-Ia afferents only evoke inhibition of flexor MNs.  Blue arrows indicate the 

















which specifically expresses enhanced green fluorescent protein (eGFP) under the control 
of the promoter of the glycine transporter (GlyT) 2 gene, which is a reliable marker for 
glycinergic neurons (Zeilhofer et al., 2005).  Past studies have shown that BAC 
transgenic models can successfully be used to express specific proteins under the control 
of the promoter of a known gene to label cells of interest. (Heintz, 2001).   Zeilhofer and 
colleagues showed that neurons expressing GlyT2-EGFP were intensely fluorescent, and 
their dendrites and axons could be visualized in great detail, but they did not justify their 
results in a quantitative manner.  They simply commented that “the vast majority of 
eGFP-positive cells were strongly immunoreactive for glycine” (Zeilhofer et al., 2005). 
Also all the experiments were carried out using adult mice. As one of the focuses of this 
study, we wanted to quantify for the first time eGFP-glycine coexpression in the GlyT2-
eGFP mouse model.   
Another focus of our study was identifying inhibitory IaINs from among other 
inhibitory neurons in the ventral spinal cord, and focused on mapping and locating IaINs 
to further understand the anatomical organization of IaINs in this sensory motor circuit. 
Past studies have looked into the location of IaINs in adult animals (Jankowska, 1992), 
but we wanted to measure the IaINs located in the lamina VII in a quantitative way using 







Locomotion is fundamental to an animal’s life and is controlled by neuronal 
networks in the central nervous system (CNS). Coordinating complex movements 
involve multiple elements of the CNS, such as cortex, cerebellum, basal ganglia, 
brainstem, and spinal cord. Different motor control features are provided by each 
component. Neuronal circuits contained entirely within the spinal cord produce basic 
rhythmicity and patterning for stepping and other locomotion behaviors.  There is limited 
knowledge of how spinal cord circuits develop and how different types of neurons are 
generated, specified, and incorporate themselves into these circuits. In order to 
understand the maturation of motor control, and potential abnormalities and dysfunctions 
that may occur during early development, it is very important to understand how and 
when initial connections are made in this pathway, and how and when their maturation 
occurs. 
 Past studies in the cat, by Eccles, Lundberg, Jankowska and others went a long 
way toward defining the spinal reflex circuitry in adult animals including the properties 
of the constituent interneurons and their actions on MNs. Most studies examining the 
neural circuits involved in quadripedal locomotion have been undertaken in adult cats and 
rodents (Eccles JC, 1968; Lundburg A, 1979; Jankowska E, 2001; Jankowska E. & 
Edgley S., 1993). Experiments in the cat, in particular, have helped in understanding 
pathways of spinal reflexes in terms of their organization and how sensory feedback is 
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involved in shaping movements.  Sensory feedback is essential for starting and 
maintaining the correct locomotor rhythm. Recordings from the cat spinal cord have 
identified and characterized some of the interneuron cell types that are interposed in these 
spinal sensorimotor pathways. (Eccles JC, 1968, Lundburg A, 1979, Jankowska E, 2001, 
Jankowska E. & Edgley S., 1993). The analysis of motor behaviors has long been at the 
center of efforts to understand how the nervous system is organized and functions, with 
Sherrington’s studies providing important first insights into the integrative nature of 
neural pathways, the reflex arc, and the control of reciprocal motor actions by central 
inhibitory pathways (Sherrington, 1906).   
This thesis revolved around identifying inhibitory IaINs from other neurons, and 
also focused on mapping and locating IaINs to set the stage for further experiments to 
understand the functionality of IaINs in sensory motor circuits. Inhibitory networks like 
recurrent and reciprocal inhibition control the activity of adult motoneurons (Pierrot-
Deseilligny & Burke, 2005). Recurrent inhibition is a process of inhibition of motor 
neurons by particular interneurons termed Renshaw cells (RCs) that receive excitatory 
inputs from motor axons (Eccles et al., 1954).  This is in contrast to reciprocal inhibition 
whereby inhibition of antagonist motor pools is evoked by stimulation of proprioceptive 
afferents (Eccles et al., 1956). Renshaw cells and IaINs have different functional roles 
and connections in an adult but they are both located in lamina VII (Jankowska, 1992) in 




A. Reciprocal Inhibition (RI) in adults: 
 The demonstration that the contraction of a muscle is accompanied by the 
relaxation of its antagonist was shown by Sherrington in 1897 who named this effect 
“reciprocal inhibition”.  The possibility that reciprocal inhibition was mediated by Ia 
afferents directly affecting MNs was postulated by Lloyd (1941). However, more than a 
decade later, Eccles demonstrated in 1956 that an interneuron (IN) was interpolated in the 
reciprocal inhibitory pathway. This interneuron was first called the “Ia intermediate 
interneuron”, which evolved into its current name, “Ia inhibitory interneurons (IaIN)” 
The reciprocal inhibitory circuit as we know it today involves Ia afferents originating in 
the muscle spindle primary endings that exert monosynaptic excitatory action onto IaINs 
that act to inhibit motor neurons of the antagonistic muscle (Eccles and Lundberg, 1958). 
 
B. Early Development of Reciprocal Inhibition: 
 Appropriate Ia afferent connections must be made with specific IaINs and those 
IaINs must make further contacts with their targeted MNs for the normal development of 
RI circuits. For example, Quadriceps (Quad) Ia afferents make connections with specific 
IaINs during development, such that when stimulated by Quad Ia afferents, these IaINs 
inhibit the MNs projecting to hamstrings muscles which act as antagonists to Quad at the 
knee joint.  How and when these connections made at embryonic stages is still unknown. 
One can assume that initially IaINs may be contacted by Ia afferents from many, 
including inappropriate, muscle sources.   During development, reinforcement of Ia-IaINs 
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connections that lead to appropriate inhibition might take place as the animal ages, 
whereas any inappropriate connections may be weakened or disappear. 
C. Role of IaINs in adults:  
 The sensory-motor circuit that mediates RI acts to prevent the co-contraction of 
antagonist flexor and extensor muscles (Figure 1). IaINs receive inputs from Ia 
proprioceptive afferents and generate reciprocal inhibition by inhibiting motoneurons in 
motor pools innervating muscles that are antagonists of the muscle of origin of the Ia 
afferent (Eccles et al., 1956). Earlier studies have shown that IaINs are found in lamina 
VII of the ventral horn of the spinal cord.   Subpopulations of interneurons with opposite 
actions, those mediating Ia reciprocal inhibition from flexors to extensors and from 
extensors to flexors of a given joint, have been found to inhibit each other (Hultborn et 
al., 1976) and their activity can be controlled by Renshaw cells (Hultborn et al., 1971).  
 
D. Early development of IaIN: 
 Interneurons (INs) and MNs are the two general classes of neurons in the spinal 
cord. MNs generate the motor output to the muscle, while INs establish local circuits that 
control the activity of MNs. Initial developmental studies focused on  MN development 
(Jessell, 2000).  Recently, interest has turned to spinal cord INs. Previous studies have 
shown that IaINs, which mediate reciprocal inhibition, derive from V1 interneurons 
(Alvarez et al., 2005).  The finding that all adult spinal INs develop from a few 
embryonic subclasses; six dorsal (dl1, dl2, dl3, dl4, dl5, and dl6) and four ventral (V0, 
V1, V2, and V3) was a major breakthrough (Goulding, 2009).  Each of these interneuron 
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classes are derived from distinct progenitor domains located in different regions of the 
proliferative neuroepithelium in the early neural tube.  The expression of the engrailed-1 
(En-1) transcription factor was found to be a key marker for V1 interneurons (Sapier et 
al., 2004). Past studies undertaken using adult mice, has shown that out of the total V1 
interneuronal population, 10% of interneurons were counted as   RCs and 13% were 
counted as IaINs (Alvarez, 2005).  
 
E. Location, anatomy and morphological identification:  
 IaIN’s position in the ventral horn was first determined from electrophysiological 
recordings (Hultborn et al., 1971) and they also showed that IaINs are directly inhibited 
by RCs located in the same spinal segment as the IaIN (Hultborn et al., 1971). More 
specific information on exact location came from intracellular labeling of IaINs. They 
were found in lamina VII (LVII) dorsal or medial to lamina IX (Burke et al., 1971, 
Jankowska 1992). IaINs are always located in the same spinal cord segment as the Ia 
afferents that excite them.  Therefore, to exert reciprocal inhibition between pools of 
motoneurons located segments away, the axons of IaINs need to ascend or descend in the 
white matter surrounding the ventral horn and then send collaterals to target motor pools 
either locally or several segments away (Jankowska and Lindstrom, 1972).  In our study, 
we identified IaINs by looking for eGFP positive neurons that received Ia afferent inputs, 





F. GlyT2-GFP Transgenic Mice Model: 
 Biomedical research to study developmental biology has been enhanced by using 
transgenic mice as animal models. Bacterial Artificial Chromosome (BAC) DNA vectors 
have been developed to hold much larger pieces of DNA that serves as the promoter 
regions for specific genes than normal plasmid vectors.   BAC transgenic mice models 
can be generated by microinjecting purified BAC DNA into the nucleus of fertilized 
mouse eggs.   
 To shed some light on the morphological and functional characteristics of 
glycinergic neurons, Zeilhofer and his team generated BAC transgenic mice.  The BAC 
clone 365E4 (179,508 base pairs long) used by Zeilhofer and his team, contained the 
entire glycine transporter 2 (GlyT2) gene and an additional 105 kb DNA flanking the 5’ 
end of exon 1 and 21 kb DNA flanking the 3’ end of the last exon. The facilitation of 
eGFP expression was carried out by removal of exon 2 at the beginning of GlyT2 gene 
using a two-step homologous recombination procedure and inserting eGFP cDNA in the 
place of exon 2. Several homologous recombination and restriction digest steps were 
carried out to remove unwanted vector sequences and to achieve the final result: a 
transgenic mouse line which expressed enhanced GFP (eGFP) under the control of the 
promoter of the glycine transporter gene 2 (GlyT2). 
 For our experiments, an active breeding colony of BAC-GlyT2-eGFP mice had 
been established in our animal facility at Wright State University with Dr. Zeilhofer’s 
permission. Thus in the present study,  we will demonstrate the eGFP-Glycine percentage 
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overlay in a quantitative way using BAC-GlyT2-eGFP transgenic  mice model at  
embryonic day E17.5, and postnatal day P0 and P1. We will then locate and measure in a 
quantitative manner the percentage of IaINs in comparison to the other glycinergic 





III. SPECIFIC AIMS 
 
Aim 1: To test and validate in a quantitative manner the GlyT2-eGFP transgenic mice 
model at late embryonic and early postnatal stages.  GlyT2-GFP is a transgenic mouse 
line in which green fluorescence protein (GFP) is expressed under control of the GlyT2 
(neuronal glycine transporter) promoter (Zeilhofer et al., 2005).  Previous studies have 
demonstrated expression of GFP in this mouse model in glycinergic neurons in the brain 
and spinal cord of an adult mouse, but did not quantify whether GFP was expressed in all 
glycinergic neurons.  We are looking to quantify the percent eGFP-Glycine co-expression 
overlap by manually identifying GFP positive cells and then measuring the intensity 
glycine expression from confocal image stacks using Image-Pro software. Several 
sections from a single animal were averaged and then total average values (±SEM) from 










Aim 2: To identify and measure in a quantitative manner immunohistochemically 
defined IaINs in the ventral horn of the spinal cord in GlyT2-eGFP postnatal mice.  IaINs 
are glycinergic neurons that mediate reciprocal inhibition and previous studies have 
shown that these neurons are located in lamina VII of the ventral spinal cord.  We 
quantified the abundance of IaINs in comparison to the total number of GlyT2-eGFP 
positive cells found in the lamina VII of postnatal spinal cord.  Several sections from a 
single animal were scanned with confocal imaging and analyzed for IaINs and the total 














IV. MATERIALS & METHODS 
 
A. Animals used for the experiments:  
 All animal procedures were performed according to National Institutes of Health 
guidelines and were reviewed by the local Laboratory Animal Use Committees at Wright 
State University. For our experiments, an active breeding colony of BAC-GlyT2-eGFP 
mice had been established in our animal facility at Wright State University with Dr. 
Zeilhofer’s permission. 
 Time-pregnant females for GlyT2-eGFP transgenic mice model were created by 
mating GlyT2-eGFP positive males with C57/BL6 wild-type females. Once mated, 
regular vaginal plug checks were carried out every morning to record the time of the 
pregnancy. Once plugged, the females were separated into different cages and the time 
and date of the plug was recorded. The plugged females were then observed till 
embryonic day 17.5 and then euthanized to isolate the embryos. The embryos were 
genotyped using a fluorescent dissecting microscope to visualize the strong GFP signal 
through the skin of the embryo.  Positive embryos were then further used for 
immunohistochemical experiments.  
 For P0/P1 pups, GlyT2-eGFP males were mated with C57/BL6 wild-type females 
as described for matings to generate embryos.  On the day of birth, the litter was 
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genotyped using a fluorescent dissecting microscope to visualize the strong GFP signal 
through the skin of the pup. Positive pups were used for further immunohistochemical or 
retrograde labeling experiments.  
 
B. Tissue Preparation for analysis: 
EGFP-Glycine overlay (E17.5): 
Time pregnant females were euthanized with Euthasol (pentobarbital) at E17.5 and 
embryos removed and transferred into an oxygenated ACSF solution.  A ventral 
laminectomy was carried out on GFP positive embryos to expose the spinal cord and the 
spinal cord was submerged in tubes of paraformaldehyde for 2 hours (post fixed).  
Afterwards the spinal cord was washed with PBS (either 2-4 hours or overnight) and was 
then transferred into tubes of 30% sucrose solution (either 2-4 hours or overnight). A 
portion of the L4-L6 region of the spinal cord was cut and frozen onto a cutting block via 
Tissue Freezing Medium (OCT, Tissue Tek). The frozen tissue blocks were then cut into 
12 micrometer sections using a cryostat and mounted directly on a slide for further 
immunohistochemistry. 
 
EGFP-Glycine overlay (P0/P1): 
Neonatal P0/P1pups were anesthetized via exposure to ice cold water for 
approximately 2 minutes then transcardially perfused with 5ml of ice-cold 
paraformaldehyde (PFA). Pups were then eviscerated and decapitated. A ventral 
laminectomy was carried out and the spinal cord was isolated into tubes of 
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paraformaldehyde for 2 hours (post fixed).  Afterwards the spinal cord was washed with 
PBS (either 2-4 hours or overnight) and was then transferred into tubes of 30% sucrose 
solution (either 2-4 hours or overnight). A portion of the L4-L6 region of the spinal cord 
was cut and frozen onto a cutting block via Tissue Freezing Medium. The frozen tissue 
blocks were then cut into transverse 12μm sections using the cryostat and mounted 
directly on a slide for further immunohistochemistry. 
 
Retrograde labeling of primary afferents: 
 Retrograde labeling of primary afferents can be achieved by dorsal root fill 
technique.  This strategy labels all types of afferents, but different types of afferents have 
different termination zones. Ia afferents extend their axons and make contacts with IaINs 
in lamina VII and MNs in lamina IX (Brown & Fyffe, 1978).  Ib afferents, another 
proprioceptive afferent type, extends its axons and terminates in more dorsal lamina of 
the spinal cord (Brown & Fyffe, 1978). Group II muscle spindle secondary afferents, 
even though they terminate in the same lamina as Ia afferents, are not known to make 
contacts with IaINs (Jankowska, 1992). Thus, primary afferent terminals making contacts 
with IaINs can be identified by their unique termination zone following retrograde 
labeling through dorsal root-fill experiments.  
 The neonatal mice P0/P1 [n=4] GlyT2-eGFP transgenic mice utilized in this study 
were anesthetized via exposure to ice-cold water for approximately 2 minutes. The mice 
were then transcardially perfused with 5ml of ice-cold oxygenated artificial cerebrospinal 
fluid (ACSF; containing in mM: 127 NaCl, 1.9 KCl, 1.2 KH2PO4, 1 MgSO4•7H2O, 26 
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NaHCO3, 16.9 D(+)-Glucose monohydrate, and 2 CaCl2). Mice were decapitated and 
eviscerated. The vertebral column, including the spinal cord, was then transferred into a 
recirculating bath of ice-cold oxygenated ACSF. This was followed by a dorsal 
laminectomy of the spinal column and careful removal of the dura from the spinal cord. 
All the ventral roots on both the sides of the spinal cord as well as all the dorsal roots of 
lumbar segment were cut, except dorsal root L4 was kept intact on the side of interest. 
The hemisected spinal cord was then pinned down in a sylgard covered dish filled with 
recirculating oxygenated ACSF at room temperature while setting up the pipettes filled 
with Rhodamine dextran to label the primary afferents in dorsal root L4. The dye 
transportation takes place via active metabolic processes and requires overnight 
incubation (<18 hours). The next morning the spinal cord was isolated into a tube of 
paraformaldehyde for 2 hours (post fixed).  Afterwards the spinal cord was washed with 
PBS (either 2-4 hours or overnight) and was then transferred into tubes of 30% sucrose 
solution (either 2-4 hours or overnight).  A portion of L4-L6 segment of the spinal cord 
was then cut and frozen into a cutting block via Tissue Freezing Medium. The frozen 
tissue blocks were then cut into transverse 20μm sections using a cryostat and mounted 











Figure 2: Illustration of retrograde labeling of primary afferents via lumbar 4 
dorsal root (DR4).  Sensory axons in the dorsal root (red) are labeled via a rhodamine 
dextran filled micropipette.  Sensory axon projections can be visualized in ventral spinal 
cord, including lamina VII and lamina IX.  We focused our analysis on eGFP positive 
glycinergic neurons (green pentagons and squares) are located in lamina VII, surrounding 
lamina IX in the ventral horn of the spinal cord. This technique allows labeling of all 
primary afferent classes projecting in DR4. The green square shaped cells labeled with 

























 Slides of fixed E17.5 and P0/P1 tissue were taken through a step-by-step process 
of one PBS ( 0.1 M Phosphate Buffer Saline) wash for five minutes followed by 
immersion in a citrate buffer solution, which works as an antigen retrieval agent to 
enhance the glycine signal, for 20 mins at 95°C.  Slides were then washed again in PBS.  
Next, the slides were incubated in Normal Donkey Serum (NDS) solution for an hour 
(Blocking Buffer (1X PBS + 1% Bovine Serum Albumin (BSA) + 10% Triton) + 1:100 
NDS) to block the background. Primary antibodies (rat α glycine (Gly), 1:800 and mouse 
α Neuronal Nuclei (Neu N), 1:1000) were then added onto the slides and left on 
overnight at 4ºC. The slides were then washed twice with PBS (5 mins each) before 
adding the secondary antibodies (Cy3 donkey α rat, 1:1000 and Cy5 donkey α mouse, 1: 
1000) for 2-4 hours at room temperature. The slides were then taken through three PBS 
washes (5 mins each) before being cover slipped using Vectashield mouting medium 
(Vector Laboratories).  
 
Retrograde labeling experiments:  
 Slides with fixed P0/P1 tissue were first washed one time with PBS for five 
minutes.  Next, the slides were incubated in NDS solution for an hour to reduce 
background signal. Primary antibodies (guinea pig α rhodamine (RHOD), 1:5000 and 
rabbit α calbindin (CB), 1:1000) were then added on to the slides and left on overnight at 
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4ºC. The slides were then washed with PBS twice (5 mins each) before adding the 
secondary antibodies (Cy3 donkey α guinea pig, 1:100 and Cy5 donkey α rabbit, 1: 1000) 
for 2-4 hours at room temperature. The slides were then taken through three PBS washes 
(5 mins each) before being cover slipped using Vectashield mouting medium.  
 
Imaging: 
The slides were imaged and analyzed using an Olympus FV1000 confocal microscope.  
Fluorophores were excited with line lasers of 405nm, 488nm, 568nm, and 633nm. 
 
Analysis: 
Images were composed using Fluoview (FV) software, Image Pro Plus 5.1, and 
CorelDraw 14. Brightness, contrast and sharpness in the images were enhanced without 












Table 1: Antibodies used for immunohistochemistry 
Antibody Dilution Host Manufacturer Lot# 
     
Green Fluorescence 
Protein (GFP) 
1:5000 Sheep ABD Serotec 4745-1051 
Glycine (GLY) 1:800 Rat Immuno solution 161002 
Calbindin (CB) 1:1000 Rabbit Swant CB38a, 9.03 
Neuronal Nuclei (Neu. N) 1:1000 Mouse Millipore LV1825845 
Vesicular Glutamate 
Transporter  1 (VGLUT1) 
1:10,000 Guinea Pig Chemicon LV1567574 
Glycine Transporter 2 
(GlyT2) 
1:2000 Guinea Pig Millipore NG1809675 
anti sheep DyLight 488 1:1000 Donkey  Jackson Immuno 
Lab 
97222 
anti rat CY3 1:1000 Donkey Jackson Immuno 
Lab 
100582 
anti guinea pig CY3 1:1000 Donkey Jackson Immuno 
Lab 
96577 




anti mouse DyLight 649 1:1000 Donkey Jackson Immuno 
Lab 
97084 
anti rabbit Alexa 647 1:100 Donkey Jackson Immuno 
Lab 
99912 
     







Aim 1: To test and validate in a quantitative manner the GlyT2-eGFP transgenic mice 
model at late embryonic and early postnatal stages. 
 The work in our laboratory is looking to better understand the early development 
of the sensory motor circuit that mediates reciprocal inhibition.  Reciprocal inhibition is 
achieved via a class of glycinergic interneurons that receive Ia afferent input and act to 
inhibit motor neuron targets.  One tool that can be used to assist in identifying these 
specific interneurons is a transgenic mouse model wherein glycinergic neurons express 
GFP (Zeilhofer, 2005).  To lay the foundation for future experiments, we needed first to 
validate expression of GFP in this mouse model in a quantitative manner.  
  BAC transgenic mice models can be generated to express a specific reported 
protein under the control of a promoter of a known gene in order to identify the cells of 
interest (Heintz, 2001).  This technique was applied by Zeilhofer and colleagues to label 
glycinergic neurons, based on expression of GlyT2 in subsets of neurons (Zeilhofer et al., 
2005). A statement that “the vast majority of eGFP-positive cells were strongly 
immunoreactive for glycine” was made by Zeilhofer and his team in 2005 (Zeilhofer et 
al., 2005). Yet, so far no one has carefully tried to measure the eGFP expression overlap 
with glycine immunoreactivity in a quantitative manner.  In addition, no analysis of the 
model at earlier stages, including in embryos, has been performed.  Therefore, our first 
aim was to test and validate the BAC-GlyT2-eGFP mouse model at early developmental 
stages in a quantitative manner.
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 A subset of neurons in the spinal cord use glycine as a neurotransmitter.  Glycine 
is also a fundamental amino acid and must be packaged into synaptic vesicles for release 
as a neurotransmitter.  The protein in neurons that is responsible for this is glycine 
transporter type 2 (GlyT2).  The promoter of the GlyT2 gene was used to construct a 
BAC used in the transgenic animal model we are studying.  We used immunoreactivity 
for GlyT2 and glycine as key markers to carefully quantify the percentage overlap with 
GFP expression in GlyT2-EGFP animals.  We collected lumbar spinal cord tissue from 
GlyT2-eGFP positive animals at embryonic day 17.5 (E17.5; n=4) and postnatal day 0 
and 1 (P0/P1; (n=5). Previous studies have shown that sensory-motor connectivity begins 
at E17.5 and one of the focuses of our study in future would be to understand the function 
of RI at birth, hence the reason we chose these two time points for our current study. 
Genotyping of embryos was facilitated by strong GFP fluorescence signal in the spinal 
cord that was visible through the skin using an epifluorescence dissecting microscope. 
Genotyping was confirmed by post hoc PCR. 
 First, we determined if the native eGFP signal in GlyT2-eGFP animals was strong 
enough after fixation to allow for analysis, or whether signal enhancement with 
antibodies against GFP was required to detect weakly labeled cell structures.  We 
performed this analysis using both 50µm floating sections as well as 12µm tissue sections 
fixed to slides. Selected GFP+ cells were visualized by confocal laser scanning 
microscopy with or without antibody staining against GFP in different tissue sections.  
We found even the finest neuronal processes could be seen without antibody staining, and 
that sections stained with the antibody showed poor penetration.  This experiment 
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revealed that anti-eGFP antibodies did not penetrate more than 6-8µm from the surface 
using either 50µm floating sections or 12µm tissue sections fixed to slides.  In addition, 
anti-GFP staining did not label more neuronal structures than seen with native eGFP 
fluorescence after fixation (data now shown). Therefore, all following experiments were 
performed without further amplifying the eGFP fluorescence (see Figures 3A, 4A for 
examples). 
 Initially we attempted to validate the faithfulness of GFP expression in GlyT2-
eGFP mice using an antibody against the membrane-bound glycine transporter 2 (GlyT2). 
Previous studies have shown that immunoreactivity (IR) for GlyT2 is a reliable marker 
for glycinergic neurons in the CNS (Poyatos et al., 1997; Liu et al., 1993).  Only axon 
terminals are labeled by GlyT2 antibodies (Spike et al., 1997) as this transporter is 
concentrated at axon terminals in order to load synaptic vesicles with glycine.  In our 
hands, although the GlyT2 antibody was able to label the axon terminals in adults, GlyT2 
IR was not distinct in E17.5 embryos and P0-P1 pups (data not shown). The GlyT2 signal 
in the axon terminals of E17.5, P0 and P1 tissue sections was very weak compared to the 
background, which made it impossible to accurately measure the GlyT2-eGFP expressing 
cells in a quantitative manner. 
To show the general positioning of all neurons in spinal cord, we used the pan-
neuronal marker NeuN (Figure 3C, 4C).  This allowed us to identify the pools of large 
motor neurons in lamina IX of the ventral horn. Visualizing the border of lamina IX was 
important for our study as we were focusing on studying the glycinergic neurons in the 






Figure 3: Representative section illustrating glycine in a transgenic GlyT2-eGFP 
mouse at E17.5 A) Transverse section of L4 ventral horn showing eGFP expression in a 
GlyT2-eGFP embryo. B) Immunoreactivity for glycine on the same section. C) 
Immunoreactivity for NeuN on the same section.  A pool of large neurons (motor 
neurons) is clearly seen to be labled with pan-Neu N in lamina IX. D) Overlay of A and 
B showing co-localization of eGFP (green)-glycine (red) in neuron somata. E) Merged 
view of A, B and C showing eGFP-glycine overlay in yellow and NeuN labeled cell 






















Figure 4: Representative section illustrating glycine in a transgenic GlyT2-eGFP 
mouse at P0/P1. A) Transverse section of L4 ventral horn showing eGFP expression in a 
GlyT2-eGFP mouse at P0/P1. B) Immunoreactivity for glycine on the same section. C) 
Immunoreactivity for NeuN on the same section.  A pool of large neurons (motor 
neurons) is clearly seen to be labled with pan-Neu N in lamina IX. D) Overlay of A and 
B showing co-localization of eGFP (green)-glycine (red) in neuron somata. E) Merged 
view of A, B and C showing eGFP-glycine overlay in yellow and NeuN labeled cell 



















paraformaldehyde fixation, strong eGFP fluorescence was observed in both embryonic 
and postnatal spinal cords tissue sections (Figure 3 A, F & 4 A, F) and hence further 
amplification of the signal was not needed. The eGFP fluorescence was readily seen in 
subsets of neurons throughout the spinal cord with the exception in lamina IX, where MN 
cell bodies are located.  
 Visual inspection of the staining patterns of glycine and NeuN using the GlyT2-
eGFP mice model at embryonic and postnatal stages, revealed that at E17.5 neurons were 
found to be generally more densely packed in the ventral horn of spinal cord (Figure 3A, 
C) in comparison to the more evenly distributed band of eGFP-Glycine expressing 
neurons seen adjacent to lamina IX at P0 and P1 (Figure 4A, C). By eye one can easily 
see a degree of overlap between the eGFP and glycine (Figures 3&4) but further analysis 
was carried out to quantify the eGFP-Glycine overaly.  
 From figure 3 and 4, we can say that there was a good degree of overlay between 
eGFP and glycine expression; however after taking a closer look by looking at the images 
taken at higher magnification using confocal microscopy, we observed that there were a 
few cells which strongly expressed eGFP but had either weak or no expression of glycine 
(Figure 5). Similarly, it was also observed that there were couple cells in each section 
which displayed strong glycine signal, but very weak EGFP signal. The fact that we 
noticed some cells were weakly expressing eGFP but strongly expressed glycine or vice 
versa when visualized by confocal laser scanning microscopy, did not imply that the 
eGFP or glycine expression was completely absent in them, the reason being that the 
expression might still be there but may have overwhelmed by the strong expression of 
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one or the other channel and therefore not visible at a glance. Hence to measure the 
degree GFP-Glycine overlap we used a software called Image Pro, which allowed us to 
manually map out the eGFP positive cells in the lamina VII by drawing a trace around the 
cell and then objectively measure the intensities for eGFP and glycine (Figure 6). 
 Image-Pro software measures the highest pixel intensity of multiple channels of 
the traced cell derived from a three dimensional image. After identifying GFP positive 
cells and drawing regions of interest around the cells using one of the drawing tools in an 
Image Pro, we limited the intensity measurement to those particular regions. Background 
intensities were then measured by separately drawing regions of interest in the neuropil to 
decide on the cut-off point for both eGFP and glycine channels for every single image 
analyzed Intensities of as many GFP positive cells as could be found in lamina VII in 
each image were manually traced and measured.  In addition, five background intensities 
for EGFP–Glycine overlay were measured by tracing the background signal for every 
single image. The average of background intensities of eGFP and glycine were then 
calculated separately and a 10% cut off point intensity was selected, i.e. a cell expressing 
10% higher signal than the background cut off point was counted as a positive cell and 
cells with fluorescent intensity within or below the 10% background cut off point were 
discarded from the final result count for each channel. The rationale for selecting a 10% 
cut off point for both the channels was due to the higher background signal for glycine in 
comparison to the actual glycine positive cells. It was noticed that by raising the cutoff 
point to more than 10%, we were discarding some actual glycine positive cells labeled in 













Figure 5: Demonstration of immunoreactivity of an antibody against glycine in a 
transgenic GlyT2-eGFP mouse spinal cord. A) View of a transverse section of L4 
ventral horn showing eGFP expression (green) in a GlyT2-eGFP mouse. The arrow 
labeled in yellow points at a cell which is eGFP positive but was found to be negative for 
glycine IR. The blue arrows are pointed towards the cells which are IR for glycine, but 
lacked in expressing eGFP. The white arrows represent eGFP positive neurons which are 
also IR for glycine. B) Transverse section of L4 ventral immunostained with an antibody 
against glycine (red) in a GlyT2-eGFP mouse.  C)  Overlay of A and B showing co-
localization of eGFP (green)-Glycine (red) in neuron somata and dendrites. The white 





















Figure 6: Representation of eGFP-Glycine overlay analysis in a GlyT2-eGFP mouse. 
A) Regions of interest (numbered 1-5) drawn around strong eGFP expressing cells 
(green). Letter B represents similar sized regions which were manually mapped to 
measure GFP and glycine signal intensity in background to decide the cutoff point. B) 
View of eGFP-Glycine expressing neurons showing almost perfect overlap. The cells 1, 2 
and 3 were eGFP expressing cells which were also strongly IR for glycine. Cells 4 and 5 




















eGFP positive cells mapped manually (figure 6A) using a drawing tool to measure the 
eGFP and Glycine intensities and three background regions mapped to work out the 10% 
cut off point. After the analysis, cells 1, 2 and 3 were counted as eGFP-Glycine positive 
cells (figure 6B).  Due to glycine intensity below the cutoff point, cells 4 and 5 (figure 
6B) were counted as glycine negative cells. 
 Data from a total of four animals for E17.5 and a total of five animals for P0/P1 
were collected and are displayed in Tables 2 and 3. Several sections from each animal 
were analyzed and averaged. Then the total average values (±SEM) from E17.5 (n=4) 
and P0/1 (n=5) were plotted into graphs (Figures 7 and 8). These results showed that at 
E17.5, 90.7% eGFP positive cells were also positive for glycine and 98.1% of glycine 
positive cells were eGFP positive (Figure 7). At P0/P1, 90.3% of eGFP positive cells 




















































Figure 7: Graphical representation of the percent eGFP-Glycine overlay at E17.5 in 
the lamina VII of a GlyT2-eGFP mouse model. The green bar shows the percentage of 
eGFP expressing cells which were also found to be positive for glycine. The percent 
GFP-Glycine overlap was analyzed manually, by identifying GFP positive cells and then 
measuring the intensity of the glycine channel using Image-Pro software.  Several 
sections from a single animal were averaged and then average values (±SEM) from E17.5 
(n=4)is plotted in this graph.  The red bar represents the percentage of all the glycine 










Figure 8: Graphical representation of the percent eGFP-Glycine overlay at P0/P1 in 
the lamina VII of a GlyT2-eGFP mouse model. The percent GFP-Glycine overlap was 
analyzed manually, by identifying GFP positive cells and then measuring the intensity of 
the glycine channel using Image-Pro software.  Several sections from a single animal 
were averaged and then average values (±SEM) from P0/1 (n=5) is plotted in this graph.  
The green bar represents the percentage of all GFP positive cells which were observed to 
be strongly labeled with glycine.  The red bar represents the percentage of all the glycine 




















These results confirmed that the BAC-transgenic mice model expresses intense 
and stable green fluorescent protein (eGFP) under the control of the GlyT2 promoter, 
specifically in glycinergic neurons and can help to identify numerous eGFP-expressing 
neurons throughout the spinal cord at as early as E17.5 time point. Further it was 
observed that the EGFP-Glycine expression and distribution was consistent at both the 



















Aim 2: To identify and measure in a quantitative manner, immunohistochemically 
defined IaINs in the ventral horn of the spinal cord of early postnatal mice. 
 In this study, Ia inhibitory interneurons (IaINs) were identified using 
immunohistochemical markers.  Having validated the GlyT2-eGFP mouse model as 
faithfully expressing GFP in glycinergic neurons, we were able to use this model in our 
analysis of IaINs.  Our criteria for identification of IaINs included: eGFP expression in 
neurons receiving synaptic contacts from CB-IR Renshaw cell axons as well as from Ia 
afferents.  The relative abundance of IaINs among all glycinergic neurons located in the 
ventral horn is unknown, and estimating the number of IaINs among all GlyT2-eGFP 
neurons will set the stage for future studies investigating the properties of these neurons.  
Because these future functional studies will focus on properties of IaINs in postnatal 
animals, we made our analysis of IaINs in lumbar spinal cords from P0/P1 mice.  
Numbers of IaINs were quantified by manual analysis of confocal image stacks. 
 An important identifier an IaIN is that these interneurons are contacted by Ia 
primary afferents.  After testing several anatomical methods to label primary afferents in 
postnatal mice, we used retrograde tracing with Rhodamine-conjugated (RHOD) dextran 
from the lumbar 4 dorsal root to label primary afferents in early postnatal spinal cords.   
Several attempts were made and the four experiments that showed the greatest degree of 
primary afferent labeling were selected to carry out further analysis. In order to enhance 
the signal in primary afferents after fixation following retrograde transport, the RHOD 
signal was further amplified using an antibody against RHOD.  Initially, we wanted to 
combine labeling of primary afferent axons with a specific presynaptic marker indicating 
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the presence of a synapse.  For this purpose, we attempted to use an antibody against 
vesicular glutamate transporter isoform 1 (VGLUT1). VGLUT1-IR has been proved to be 
a specific marker of sensory afferent terminals in postnatal and developing mice in 
previous studies. Interestingly, VGLUT1-IR in our study was found to be noticeably 
weaker at P0/P1 than at later postnatal stages (data not shown), probably because the 
protein has not been sufficiently enriched in synaptic terminals at that stage.  
Consequently, we labeled primary afferent terminals only with RHOD dextran.  
 As mentioned before, a classic property of IaINs is direct inhibition from RCs 
(Hultborn et al., 1971; Todd et al., 2003; Alvarez et al., 2004)  Anatomical studies have 
found that some INs in the ventral horn receive a dense innervation on the cell body and 
proximal dendrites from Renshaw cells (labeled with calbindin antibodies). In parallel 
with electrophysiological criteria (Alvarez & Fyffe, 2007) these INs were identified as 
IaINs (Alvarez et al. 2005; Siembab et al., 2010). In neonatal mice, RCs can be uniquely 
identified by high expression levels of the calcium binding protein, calbindin (CB) 
(Geiman et al., 2000). Synaptic terminals of RCs on MNs and spinal interneurons are first 
observed at E15.5 and are abundant by E17.5 (Siembab-Neff, 2009).  
 Figure 9 shows a low magnification (20X) image of the ventral horn of the spinal 
cord taken using a confocal microscope.  Retrograde tracing of dorsal root L4 afferents 
produced dense primary afferent labeling in the ventral horn of the postnatal P0/P1 spinal 
cord.  As shown earlier in this study, there was a clear band of eGFP labeled cells in 
lamina VII surrounding IX (Figure 9). The primary afferent labeling clearly showed 
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axons approaching and making contacts with different neurons in the ventral horn of the 
spinal cord including MNs (Figure 9). CB-IR was also very strong in some interneurons. 
 Viewed at higher magnification (60X), eGFP expressing cells in the ventral horn 
of the spinal cord could be divided into several categories. Some eGFP positive neurons 
received clear contacts from RHOD-IR primary afferents, but did not receive contacts 
from CB positive terminals (Figure 10D).  Others received CB-IR contacts, but not 
primary afferent contacts (Figure 11D).  Some received both types of contacts (Figure 
12D), and still others received no discernible contacts from primary afferents or CB-IR 













Figure 9: Illustration of retrograde labeling of primary afferents at low 
magnification in a GlyT2-eGFP mouse spinal cord. A) Confocal image of a transverse 
section of L4 showing brightly labeled eGFP cells in the ventral horn of the spinal cord. 
B) Primary afferent projections approaching from dorsal into the ventral horn of the 
spinal cord. C) Brightly labeled calbindin contacts (puncta) and strongly labeled 
calbindin cell somata shown in a confocal image of a transverse section of L4 in the 
ventral horn of the spinal cord. D) Merge view of a confocal image showing eGFP 
positive cells (green), primary afferent labeling (red), and calbindin immunoreactivity  
























Figure 10: Demonstration of retrograde labeling of primary afferents at higher 
magnification in lamina VII of a GlyT2-eGFP mouse spinal cord. A) 60X confocal 
image of brightly labeled eGFP neurons. B) Rhodamine-dextran labeled primary 
afferents viewed at 60X. C) Merged view at 60X of eGFP positive cells (green) receiving 
primary afferents contacts (puncta in red) surrounding the cells. D) Zoomed view of a 



























Figure 11: Illustration of calbindin IR at a higher magnification in the lamina VII of 
a GlyT2-eGFP mouse spinal cord. A) 60X confocal image of brightly labeled eGFP 
neurons. B) Image of strongly labeled calbindin contacts (puncta) and some neurons that 
are strongly positive for calbindin in the cell soma viewed at 60X. C) Merged view at 
60X of eGFP positive cells (green) receiving calbindin contacts (puncta in magenta) 
surrounding the cells. D) Zoomed view of a single eGFP positive cell. The arrows point 
























Figure 12: Illustration of identification of IaINs in the lamina VII of the ventral 
horn of a GlyT2-eGFP mouse spinal cord. A) A single eGFP positive cell imaged at 
60X. B) Image showing retrograde labeled afferents (red) making contacts with the eGFP 
positive cell. The arrows point to primary afferent contacts surrounding the cell. C) The 
same eGFP positive cell was observed to be receive calbindin contacts. Blue arrowheads 
point to calbindin contacts (magenta puncta) found surrounding the cell. D) Merged view 
representing eGFP positive cells (green) receiving primary afferent contacts (red) and 





















 Quantitative analysis of these cell populations was carried out by taking several 
overlapping 60X images from a single section and reassembling the images to create a 
high magnification montage of the area surrounding lamina IX using CorelDraw 
software.  A lower magnification image (20X) of the same area was used as a guide in 
assembling the montage (Figure 13).   Once the pool was mapped out in CorelDraw, each 
GFP positive cell in lamina VII of the individual 60X images was analyzed for the above 
mentioned criteria to identify and characterize IaINs.  This was performed with the 
original three dimensional image stacks using Imaris software and required analysis of 
possible synaptic contacts on a given neuron in all the individual optical sections in an 
image.    Several sections from total of four animals at P0/P1 (n=4) were analyzed and 
data for the different types of neurons identified is presented in Table 3. After averaging 
the data from different sections of the same animal, total average values (±SEM) for 
P0/P1 (n=4) were calculated (Table 4) and the percent count of different neurons 
including IaIN was plotted into a graph (Figure 14). 
  Our results show that on average,  , 16 percent of eGFP expressing cells in the 
lamina VII of ventral horn of the spinal cord did not receive any primary afferent contacts 
or RC inputs and were characterized as GFP-only neurons. eGFP expressing cells 
receiving only inputs from RHOD-IR primary afferents accounted for 22 percent of the 
total population. In contrast, more than one-fourth of the total population (29%) of eGFP 
positive cells received brightly labeled CB-IR RC contacts.  IaINs were carefully 








Figure 13: Illustration of technique used to carry out the quantitative analysis of 
IaINs found in lamina VII of a GlyT2-eGFP mouse. A) Merged 20X confocal image 
showing the retrograde labeled primary afferents (red), eGFP positive cells (green), and 
calbindin signals. Some cells strongly expressing calbindin can also be viewed in this 
image. B) Montage of several 60X images assembled in CorelDraw using the 20X 
confocal image of the same section as a guiding tool. This map was further used to locate 





















Figure 14: Graphical representation identified subsets of eGFP neurons found in  
lamina VII of GlyT2-eGFP P0/P1 mice.   eGFP expressing cells in lamina VII were 
divided into several groups based on contact status from primary afferents and calbindin 
IR terminals.  Average values for each group (±SEM) derived from P0/1 animals (n=4) 




























and CB-IR RC inputs measured in quantitative manner and accounted for 17 percent of 
the glycinergic neurons in lamina VII. Lastly, there was a subset of eGFP positive 
neurons (16%) that were observed to be strongly labeled with Calbindin in their soma but 
lacked primary afferent contacts (Table 4).   After careful consideration, we came to a 
conclusion that they do meet the criteria of being a RC hence might account for a subset 
of RCs located in lamina VII of a spinal cord. Altogether, our study proved that GlyT2-
eGFP transgenic mice model can be successfully used to identify and quantify the IaINs 


















 Our analysis has shown that GlyT2-eGFP mice model is a most useful and 
powerful tool for immunohistochemically labeling glycinergic neurons at early 
developmental stages like embryonic day 17.5, postnatal day 0 and day1.  
 Based on the consistency of eGFP-Glycine overlay results between E17.5 and 
P0/P1, we can suggest that the model is as accurate in identifying IaINs at E17.5 as it is 
for postnatal day 0 and 1. Thus we are confident we can reliably use the GlyT2-eGFP 

















 Our results suggests that BAC-GlyT2-EGFP mice model allows labeling of more 
than 98% of glycinergic neurons by eGFP-Glycine overlay at late embryonic E17.5 and 
postnatal P0/P1 stage. Further our results confirmed that IaINs are found in the lamina 
VII, adjacent to lamina IX and suggests that IaINs accounts for 17% of the total eGFP 
expressing cell population in the lamina VII of ventral horn of postnatal mice spinal cord.   
  Previous studies have utilized the BAC-GlyT2-eGFP transgenic mouse model for 
studying glycinergic neurons. One study concluded that the “vast majority of either 
glycine or eGFP positive neurons were doubly labeled” for GFP and glycine (Zeilhofer et 
al., 2005).  A second study used the model as a part of their study to show that putative 
glycinergic, GABAergic, and glutamatergic commissural interneurons are expressed in 
almost equal numbers in mice spinal cord (Restrepo et al., 2009).  Restrepo and 
colleagues did not justify exactly how efficient in quantitative manner the BAC-eGFP-
GlyT2 model was in identifying glycinergic neurons at P0/P1.  Quantitative answers to 
several questions were not provided in these studies.  Were there any false positive or 
false negative labeled cells?  False positives are defined as cells which were eGFP 
positive but not glycine positive. In contrast, false negatives are defined as cells which 
were seen to be glycine positive but not eGFP positive. Thus it was important to carry out 
this study to determine quantitatively how faithful the GFP expression replicated the 
distribution of glycinergic neurons in the spinal cord.  We found that exactly 1.8 % and 
1.1% of glycine positive cells did not express eGFP in E17.5 and P0/P1 stages 
65 
 
respectively. These cells can be counted as  false negatives. The eGFP may well be 
expressed by those cells, but because the eGFP intensities in those cells were below the 
background cut off points they were counted as negative for eGFP. Whereas, we found 
9.2% at E17.5 and 9.7% at P0/P1 of eGFP positive cells which did not express glycine, 
again those can be counted as   false positives. The glycine may well be expressed by 
those 9.2% cells at E17.5 or 9.7 % cells at P0/P1, but because the glycine intensities were 
below the background cut off points they were counted  as negative for glycine. This 
suggests that the BAC-eGFP-GlyT2 mice model either lacked to express eGFP in 1-2% 
of the glycinergic neurons found in the lamina VII  at E17.5 and P0/P1 or those cells 
were “false negative cells” which were observed to strongly labeled for glycine but 
weakly (below background cut off point).labeled for eGFP.  
 The past studies which Zeilhofer and Restropo conducted using BAC-GlyT2-
eGFP mice model lacked to show the identification of glycinergic neurons at an 
embryonic stage E17.5. The eGFP expression is known to be already very high in GlyT2-
eGFP mice embryos at E13 or E14, the rationale for using E17.5, P0 and P1 for our 
studies was based on the Ia afferent to motoneuron connectivity study carried out by 
Mears and Frank in 1997.  Frank observed that axons of Ia afferents were found to be 
overlapping with the dendrites of motorneurons as early as E15.5, but did not record any 
sensory motor connections until E17.5 (Mears and Frank 1997). Even at this early stage 
the Ia afferent connectivity with homonymous motorneurons in mice was shown to be 
highly specific and remained that way throughout the first postnatal week (Mears & 
Frank, 1997). But no knowledge of the onset of Ia afferent connectivity to IaINs is gained 
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in last several years as till date. Several studies using BAC-GlyT2-eGFP mice models 
have shown to be successfully labeling glycinergic neurons including IaINs in mice 
(Zeilhofer et al., 2005; Alvarez et al., 2005; Restrepo 2009), but no one has tested the 
eGFP expression at embryonic stage, hence there was a need for testing and validating 
the model at embryonic stage before it could be further used for studying early 
developmental stages of RI circuit.  
 Our results show that at E17.5, the labeling of glycinergic neurons using BAC-
eGFP-GlyT2 is consistent with that shown at P0/P1 (<98%). However, the BAC-eGFP-
GlyT2 model lacked labeling1-2% of glycinergic cells in our study. Again those 1-2% 
cells can be counted as  false positives i.e. the glycine may well be expressed by those 1-
2% eGFP cells but the intensity of the glycine channel in those particular cells were 
below the background cutoff point and hence those cells were counted  as negative for 
glycine. . Altogether from our study we can say that the BAC-eGFP-GlyT2 transgenic 
mouse model is efficient in labeling more than 98% (98.2% at E17.5 & 98.8% at P0/P1) 
of glycinergic neurons in the spinal cord at as early as embryonic day 17.5.   
 Past studies have proved that different markers including neuropeptides or 
calcium-binding proteins like Calbindin expressed in neurons such as GABAergic 
neurons helps in defining its anatomical organization (Demeulemeester et al., 1991). The 
generation of BAC-eGFP-GlyT2 transgenic mice, which drives the eGFP expression 
under the control on GlyT2 promoter, represents additional powerful tool for studying 
functional role of glycinergic projections in the CNS (Zeilhofer et al., 2005). Although 
GlyT2 is proved to be a valuable tool for labeling glycinergic neurons in past (Poyatos et 
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al., 1997; Spike et al., 1997) it immunoreactivity is restricted to only axon terminals, 
using eGFP-GlyT2 transgenic mice model combined with immunohistochemical 
immunostaining with Glycine and GlyT2 considerably extends past observations notably 
by labeling the glycinergic neurons including their soma, dendrites and axon terminals 
(Zeilhofer et al, 2005).  
 One of the limitations for using this technique is relying on a protein expression 
driven under the promoter GlyT2 gene to label the glycinergic neurons. Glycine antibody 
labels the cell body and dendrites but sometimes there can be variability in the labeling of 
the neurons depending on the expression of the protein present in one neuron to other. In 
contrast GlyT2 is a unique gene marker for labeling glycinergic neurons.  Ideally 
immunohistochemical labeling using glycine in combination with GlyT2 would be 
optimal. An alternative technique that could have been used to confirm the glycinergic 
nature of GFP+ cells, would have combined with in situ hybridization of mRNA 
encoding glycine transporter 2 (GlyT2) with GFP expression in tissue slices. (Restrepo et 
al, 2009). In situ hybridization technique is a powerful method to identify glycinergic 
neurons as it only labels cell bodies of the neurons that almost certainly use glycine as 
their neurotransmitter. Due to the limited resources available for our present study the 
demonstration of this technique was not possible in given time, but it is something our lab 
is considering for future studies.  
 Having demonstrated the usefulness of the GlyT2-GFP model, the second focus 
of this thesis was to map, locate and identify in a quantitative manner the IaINs located in 
the lamina VII early postnatal stages using BAC-GlyT2-eGFP mice.   
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 Mears and Frank in 1997 using electrophysiology demonstrated that Ia afferent 
connectivity with motoneurons were observed to be highly specific from embryonic 
stages (E17.5) till the first postnatal week (Mears & Frank, 1997). More than a decade 
later using electrophysiology Wang and his team showed that RI circuit is functional 
even at P0 in mice (Wang et al. 2008).  Above mentioned studies suggest that the Ia 
afferent connectivity to motoneurons is highly specific even at embryonic stage but no 
one looked into how specific the Ia afferent connectivity with IaINs is? What anatomical 
or functional change takes place if any during the embryonic development of RI 
pathway? From our study we have validated that GlyT2-eGFP mice model is an accurate 
model to study the IaIN location, function and Ia afferent to IaIN connectivity in a late 
embryonic developmental stage till postnatal day P1.  
 In mature spinal cords, IaINs were previously identified histologically by 
Parvalbumin (PV)/ RC expression and proprioceptive inputs, labeled respectively by CB 
and VGLUT1 (Alvarez et al., 2005). Parvalbumin is calcium binding albumin protein 
which is found to be expressed in abundance in GABAergic neurons. Identification of 
RCs can be carried out using calcium binding protein, Calbindin (Geiman et al., 2000). 
Previous studies have shown that RC and Ia afferent inputs are a unique criteria for 
identification of interneurons mediating reciprocal inhibition in lumbar spinal cord 
(Hultborn et al., 1971; Jankowska and Lindstrom, 1972; Alvarez et al., 1997). Ia afferents 
enter the spinal cord dorsally and make contacts with the IaINs and motorneurons to 
mediate the process of RI in the ventral horn of the spinal cord (Eccles et al. 1956). This 
anatomical arrangement gives an opportunity to investigate the location of the Ia 
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interneurons in relation to the primary afferents which excites them and to other 
interneurons or motorneurons which they are supposed to inhibit. 
 In the present study anatomical tracing was carried out on L4 spinal segment by 
filling dorsal root 4 with RHOD dextran to search for Ia inhibitory interneurons. 
Characteristics of interneurons in the Ia inhibitory pathway were used as a key marker to 
identify them in the lamina VII of ventral horn of postnatal GlyT2-eGFP mice. Although 
studies in past have focused on the identification of IaINs, no one has looked into 
carefully identifying number of IaINs compare to other neurons in a quantitative way at 
neonatal stage. This quantification will allow researchers to have an idea of exactly how 
carefully one needs to look into the lamina VII to identify IaINs via electrophysiological 
assays. By knowing that out of the total cell population in the lamina VII of the spinal 
cord at postnatal stages P0 or P1, IaINs accounts for only 17% percent, sheds some light 
on probability of locating an IaIN in the lamina VII, while doing electrophysiological 
experiments for measuring their functionality in the RI circuit.  
 This study is the first to carry out identification of IaINs using GlyT2-eGFP mice 
model. One advantage using this technique is that we were able to identify the IaINs at 
postnatal day P0 and P1. The studies in past used PV as a marker to label IaINs in 
combination with Calbindin and primary afferent inputs in adult mice, and demonstrated 
that in adults IaINs accounts for 13% of the total V1 derived interneurons in the spinal 
cord (Alvarez et al, 2005).  Our analysis at early postnatal stages shows that 
approximately 17% of total eGFP expressing cell population found in the lamina VII, 
dorsal and medial to lamina IX,  were found to be IaINs. Therefore one could assume that 
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the number to IaINs do not change much as the animal develops but instead  may be the 
Ia afferent connections with IaINs strengthens in the circuit making the circuit more 
specific as the animal develops.  One step ahead from here would be identifying a 
specific protein, enzyme or neuropeptide which is restricted to only IaINs, and would 
efficiently label all the IaINs found in the ventral horn of the spinal cord.     
 Together with the identification of IaINs, the GlyT2-eGFP also demonstrated 
subset of neurons which received bright Calbindin contacts but no primary afferent inputs 
or strong primary afferents but no Calbindin contacts, those neurons may account for 
other important and interesting neurons but for now we are not aware of their functions in 
the lamina VII of postnatal mice spinal cord. 
 
Future studies: 
 For RI circuit to be functionally normal, appropriate Ia afferent connections must 
be made with specific IaINs and those IaINs must make further contacts with their 
targeted MNs. Quadriceps (Quad) and Adductors (Add) afferents make connections with 
specific IaINs in the RI pathway. For example stimulation of Quad muscle group (knee 
extensors) results in disynaptic inhibition of MNs projecting to posterior biceps / 
semitendinosus muscles (PBST, knee flexors) (Eccles and Lundberg, 1958). But 
stimulation of Add muscle group does not inhibit the PBST MNs, even though they both 
enter the spinal cord via the same dorsal root and terminate in the same area where IaINs 
are located. This suggests that the subsets of IaINs that project to and inhibit PBST MNs 
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are contacted by Quad afferents only, and not Add afferents. The RI circuit is known to 
be functional at P0 (Wang et al., 2008).  
 For future studies we want to determine the anatomical organization and 
functionality of RI circuit in the late embryonic stages to see how early in the 
development of RI circuit are those connections first made and how appropriate are those 
connections. We would like to test the hypothesis that more inappropriate Ia afferent 
connections exists prenatally than postnatally in the RI circuit. The study would be 
carried out using GlyT2-eGFP mice at embryonic stage E17.5, E18.5 and postnatal stages 
P0 and P1.We would look at the status of afferent connections with IaINs in embryos up 
till postnatal day P1, by labeling the afferents projections to specific muscles with 
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